Daniel Stauder
Stock Analyst at Citizens JMP
(4.17)
# 1,511
Out of 4,512 analysts
53
Total ratings
51.3%
Success rate
21.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Maintained: Buy | $53 → $48 | $24.03 | +99.75% | 10 | May 8, 2026 | |
| LMAT LeMaitre Vascular | Maintained: Buy | $118 → $127 | $100.29 | +26.63% | 11 | May 6, 2026 | |
| ATRC AtriCure | Maintained: Buy | $60 → $52 | $34.80 | +49.43% | 15 | Feb 18, 2026 | |
| STXS Stereotaxis | Initiated Coverage: Buy | $4 | $1.64 | +143.90% | 1 | Dec 16, 2025 | |
| STIM Neuronetics | Reiterated: Buy | $3 → $7 | $1.79 | n/a | 6 | Mar 5, 2025 | |
| AVNS Avanos Medical | Reiterated: Hold | n/a | $24.93 | n/a | 10 | Feb 28, 2025 |
Artivion
May 8, 2026
Maintained: Buy
Price Target: $53 → $48
Current: $24.03
Upside: +99.75%
LeMaitre Vascular
May 6, 2026
Maintained: Buy
Price Target: $118 → $127
Current: $100.29
Upside: +26.63%
AtriCure
Feb 18, 2026
Maintained: Buy
Price Target: $60 → $52
Current: $34.80
Upside: +49.43%
Stereotaxis
Dec 16, 2025
Initiated Coverage: Buy
Price Target: $4
Current: $1.64
Upside: +143.90%
Neuronetics
Mar 5, 2025
Reiterated: Buy
Price Target: $3 → $7
Current: $1.79
Upside: n/a
Avanos Medical
Feb 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $24.93
Upside: n/a